Cannabinoid receptor modulators
US10632134B2 · kind B2 · utility
3Cited by
7References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 2017 |
| Grant date | Apr 28, 2020 |
| Priority date | — |
| Expiry date | Feb 8, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are certain methods useful in the treatment of cancer comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.